Th9 and allergic disease
Version of Record online: 21 MAY 2009
© 2009 Blackwell Publishing Ltd
Volume 127, Issue 4, pages 450–458, August 2009
How to Cite
Soroosh, P. and Doherty, T. A. (2009), Th9 and allergic disease. Immunology, 127: 450–458. doi: 10.1111/j.1365-2567.2009.03114.x
- Issue online: 6 JUL 2009
- Version of Record online: 21 MAY 2009
- Received 3 March 2009; revised 3 March 2009; accepted 31 March 2009.
- 1Allergy and allergic diseases. First of two parts. N Engl J Med 2001; 344:30–7..
- 2Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci USA 1988; 85:6934–8., , .
- 3Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med 1989; 169:363–8., , , , , , , .
- 4Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 1990; 20:1413–16., , , , , , , .
- 5Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 1995; 85:1300–5., , , .
- 6Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9:1341–6., , et al.
- 7IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells. Nat Immunol 2008; 9:1347–55., , et al.
- 8Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993; 23:1687–92., , et al.
- 9Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 1993; 79:146–51., , , .
- 10IL-4-independent regulation of in vivo IL-9 expression. J Immunol 1997; 159:2616–23., , , , , .
- 11IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000; 105:108–15., , et al.
- 12Increased expression of interleukin-9 messenger RNA after segmental allergen challenge in allergic asthmatics. Chest 2003; 123(Suppl. 3):370S., , , , , , .
- 13Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003; 111:1319–27., , , , , , .
- 14Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004; 113:462–9., , et al.
- 15Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect Immun 2000; 68:6005–11., , et al.
- 16Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect Immun 1998; 66:3832–40., , , .
- 17A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol 1993; 1:3434–41., , , , , , , .
- 18Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene. J Immunol 1990; 144:4235–41., , , , , .
- 19IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol 1992; 148:3147–51., , , .
- 20IL-2-induced IL-9 production by allergen-specific human helper T-cell clones. Int Arch Allergy Immunol 2007; 143(Suppl. 1):71–5., , , , , .
- 21A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J Immunol 1995; 154:2624–30., , , , , , .
- 22CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol 2006; 177:6940–51., , et al.
- 23Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism. Blood 2008; 111:5163–72., , et al.
- 24IL-1 serves as a secondary signal for IL-9 expression. J Immunol 1991; 147:3848–54., , , , , , .
- 25Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur J Immunol 2004; 34:3674–81., .
- 26IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 1994; 153:3989–96., , et al.
- 27Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245–8., , , , , .
- 28Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 1993; 189:419–35., , .
- 29Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 2006; 24:607–56., , , .
- 30The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2:933–44., .
- 31A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100:655–69., , , , , .
- 32IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821–52., , , .
- 33Regulatory T cells and immune tolerance. Cell 2008; 133:775–87., , , .
- 34The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16:495–521., , , , , , .
- 35Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function. Immunol Rev 1999; 170:65–72., , , .
- 36T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 2002; 3:549–57., , , , , , , .
- 37GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 2006; 16:3–10., , , , .
- 38Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006; 17:173–88., , , .
- 39Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008; 41:87–102., .
- 40Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol 2007; 19:400–8., , .
- 41Conversion of peripheral CD4+ CD25− naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875–86., , , , , , , .
- 42Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29:44–56., , et al.
- 43Cutting edge: regulatory T cells induce CD4+ CD25− Foxp3− T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007; 178:6725–9., , , .
- 44Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256–60., , , , , , .
- 45Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009; 106:1903–8., , , , , .
- 46Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009; 30:155–67., , et al.
- 47Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442:997–1002., , et al.
- 48Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006; 12:518–25., , , .
- 49Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J Biol Chem 1996; 271:15815–22., , , , , .
- 50p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. Mol Immunol 2007; 44:926–33., , et al.
- 51Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 1989; 73:1142–8., , , .
- 52Genetic susceptibility to asthma–bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333:894–900., , , , , , , .
- 53Evidence for linkage between asthma/atopy in childhood and chromosome 5q31–q33 in a Japanese population. Am J Respir Crit Care Med 1997; 156:1390–3., , et al.
- 54Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996; 1:1280–4., , , , , , , .
- 55Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci USA 1997; 94:13175–80., , et al.
- 56Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics 1998; 52:233–5., , et al.
- 57Asthma. N Engl J Med 2001; 344:350–62., .
- 58Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298–304., , et al.
- 59IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995; 155:2688–94., , , , , , .
- 60Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy 2002; 32:866–71., , , .
- 61Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13. Clin Exp Allergy 2006; 36:174–82., , , , , .
- 62IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol 2005; 116:73–9., , , , .
- 63Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol 1998; 19:713–20., , et al.
- 64Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998; 188:1307–20., , , .
- 65IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000; 13:573–83., , , , , .
- 66The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med 2002; 195:51–7., , , , .
- 67Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002; 166:409–16., , et al.
- 68IL-9 promotes but is not necessary for systemic anaphylaxis. J Immunol 2005; 175:335–41., , , .
- 69IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008; 205:897–913., , et al.
- 70Cytokines and growth factors in airway remodeling in asthma. Curr Opin Immunol 2007; 19:676–80., .
- 71Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 2009; 15:4–11., , , .
- 72Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999; 104:1375–82., , et al.
- 73Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol 2003; 28:664–72., , , , , , , .
- 74Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J Respir Cell Mol Biol 2003; 28:286–95., , , , .
- 75Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000; 22:649–56., , , , , , .
- 76IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J Immunol 2007; 178:3244–51., , et al.
- 77Cytokine regulation of mucus production in a model of allergic asthma. Novartis Found Symp 2002; 20:77–82., , , .
- 78Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am J Respir Cell Mol Biol 2007; 37:202–9., , , , , , .
- 79Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. Am J Physiol Lung Cell Mol Physiol 2003; 284:L1093–102., , , , , , , .
- 80IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J Immunol 2004; 173:2771–9., , , , , .
- 81Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 2002; 277:35466–74., , et al.
- 82CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling. Am J Physiol Lung Cell Mol Physiol 2009; 296:L229–35., , , .
- 83The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 2006; 27:208–29., , .
- 84IL-9 in allergic inflammation. Int Arch Allergy Immunol 2004; 134:79–87., , .
- 85Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 2001; 107:575–82., , .